Biogen (BIIB)
(Delayed Data from NSDQ)
$221.50 USD
-1.25 (-0.56%)
Updated May 10, 2024 04:00 PM ET
After-Market: $221.54 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
BIIB 221.50 -1.25(-0.56%)
Will BIIB be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BIIB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BIIB
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Other News for BIIB
3 S&P 500 Stocks to Rival Nvidia’s 2023 Performance in the Second Half of 2024
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Eli Lilly Alzheimer’s therapy set for June FDA AdCom meeting
U.S. Wide-Moat Stocks On Sale - The May 2024 Heat Map
Morning Brew: Tesla's Innovative Patent Sparks Investor Interest